This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Kevin M. Sullivan, MPH, MHA; Patrick L. Remington, MD, MPH; Eugene S. Hurwitz, MD
Centers for Disease Control Atlanta

Thomas J. Halpin, MD, MPH
Ohio Department of Health Columbus

JAMA. 1988;260(23):3434-3435.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor. —

THE JOURNAL has presented convincing evidence from case-control studies that aspirin use among children increases the risk for Reye's syndrome.^1-3 In recent years, there has been a dramatic decline in the reported incidence of Reye's syndrome nationally, which has paralleled the decline in the use of aspirin.⁴ More recently, Sienko et al⁵ reported further supporting population-based evidence for the association between aspirin and Reye's syndrome, stating that decreasing aspirin use has made Reye's syndrome an "endangered syndrome." We would like to address the possible concern regarding children who routinely take aspirin for chronic illnesses.

Two studies^6,7 have shown that children who take aspirin routinely are at increased risk of Reye's syndrome. While the prevalence of juvenile rheumatoid arthritis (JRA) has been estimated to range from 0.1 to 1.1 per 1000 children,⁶ a hospital-based study⁷ of Reye's syndrome found a disproportionate . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?